Cookies Policy
X

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.

I accept this policy

Find out more here

Renal and cardiovascular toxicity of non-steroidal anti-inflammatory drugs

No metrics data to plot.
The attempt to load metrics for this article has failed.
The attempt to plot a graph for these metrics has failed.
The full text of this article is not currently available.

Brill’s MyBook program is exclusively available on BrillOnline Books and Journals. Students and scholars affiliated with an institution that has purchased a Brill E-Book on the BrillOnline platform automatically have access to the MyBook option for the title(s) acquired by the Library. Brill MyBook is a print-on-demand paperback copy which is sold at a favorably uniform low price.

Access this article

+ Tax (if applicable)
Add to Favorites
You must be logged in to use this functionality

image of Inflammopharmacology

Introduction. In addition to gastro-intestinal side effects, non-steroidal anti-inflammatory drugs (NSAIDs) have been associated with renal and cardiac complications. We review the mechanisms of NSAID-induced renal and cardiac toxicity and the epidemiological evidence regarding the magnitude of these problems.Methods. A Medline search was undertaken, using MESH and keyword terms, specified drug names, and renal/cardiac outcomes. The Cochrane Database was also searched.Results. Renal toxicity may manifest as acute or chronic failure and/or nephropathy, cardiac toxicity, as failure. For the most part, renal and cardiac side effects are consequences of interference by NSAIDs with prostaglandin-dependent processes, including homeostasis and vasodilitation/constrictor balance. Based on the epidemiological evidence, NSAID-induced vasomotor renal failure is fairly uncommon, and is usually identified and treated promptly. Factors increasing the risk include old age, pre-existing renal failure, and NSAIDs with long half-lives. In patients with existing cardiac disease, NSAIDs increase the risk of failure and may account for up to 19% of failure-related hospital admissions. The risk of renal and cardiac toxicity may be highest early in the course of treatment. NSAIDs may increase mean arterial pressure by around 5 mm Hg, an amount clinically significant in those with hypertension.Conclusions. NSAIDs may produce clinically significant renal and cardiac toxicity. Some of the factors increasing susceptibility may be identified easily, thereby permitting prescribers to either choose alternatives or look for evidence of harm in those most at risk.

10.1163/15685600052062734
/content/journals/10.1163/15685600052062734
dcterms_title,pub_keyword,dcterms_description,pub_author
6
3
Loading
Loading

Full text loading...

/content/journals/10.1163/15685600052062734
Loading

Data & Media loading...

http://brill.metastore.ingenta.com/content/journals/10.1163/15685600052062734
Loading

Article metrics loading...

/content/journals/10.1163/15685600052062734
2000-01-01
2016-12-04

Sign-in

Can't access your account?
  • Tools

  • Add to Favorites
  • Printable version
  • Email this page
  • Subscribe to ToC alert
  • Get permissions
  • Recommend to your library

    You must fill out fields marked with: *

    Librarian details
    Your details
    Why are you recommending this title?
    Select reason:
     
    Inflammopharmacology — Recommend this title to your library
  • Export citations
  • Key

  • Full access
  • Open Access
  • Partial/No accessInformation